Aspen Pharmacare slipped to 134.11 ZAR, down 0.7% on Thursday, 3 April 2026, but that move looks more like a pause than a break in trend after a 4.8% five-day climb from 127.94 ZAR. For retail investors focused on APN, the key point is not the single-session decline by itself, but the fact that the stock has held onto most of its recent gains, with an RSI of 56.95 still pointing to constructive momentum rather than an overstretched spike.
Key figures
- APN: 134.11 ZAR, down 0.7% on the day
- Five-day move: +4.8% from 127.94 ZAR to 134.11 ZAR
- Recent peak in the run: 135.00 ZAR
- RSI: 56.95
- USD/ZAR: 16.9818, up 0.98%
Market context: JSE today favours miners, not healthcare
The broader backdrop on the Johannesburg stock exchange today was not especially supportive for defensive healthcare names. The JSE All Share Index fell 0.41% to 116122.75, while the JSE Top 40 lost 0.44% to . Market breadth was still fairly balanced at against out of tracked stocks, suggesting the index weakness came from sector rotation rather than broad-based liquidation.